Language:

Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013

Emerging infectious diseases, 2016-01, Vol.22 (1), p.56-64 [Peer Reviewed Journal]

COPYRIGHT 2016 U.S. National Center for Infectious Diseases ;COPYRIGHT 2016 U.S. National Center for Infectious Diseases ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2201.150736 ;PMID: 26692336

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013
Author: Cameron, Ross L ; Kavanagh, Kimberley ; Pan, Jiafeng ; Love, John ; Cuschieri, Kate ; Robertson, Chris ; Ahmed, Syed ; Palmer, Timothy ; Pollock, Kevin G J
Subjects: Adult ; cancer screening ; Cervical cancer ; Cross Protection - immunology ; Female ; Health aspects ; herd immunity ; Human Papillomavirus Prevalence and Herd Immunity after of Vaccination Program, Scotland, 2009–2013 ; human papillomavirus vaccine ; Humans ; Immunity, Herd - immunology ; Immunization Programs - methods ; Infection ; Papillomaviridae - immunology ; Papillomavirus Infections - epidemiology ; Papillomavirus Infections - immunology ; Papillomavirus Vaccines - immunology ; Papillomaviruses ; Prevalence ; Prevalence studies (Epidemiology) ; Scotland - epidemiology ; Vaccination ; Vaccination - methods ; viruses ; Young Adult
Is Part Of: Emerging infectious diseases, 2016-01, Vol.22 (1), p.56-64
Description: In 2008, a national human papillomavirus (HPV) immunization program using a bivalent vaccine against HPV types 16 and 18 was implemented in Scotland along with a national surveillance program designed to determine the longitudinal effects of vaccination on HPV infection at the population level. Each year during 2009-2013, the surveillance program conducted HPV testing on a proportion of liquid-based cytology samples from women undergoing their first cervical screening test for precancerous cervical disease. By linking vaccination, cervical screening, and HPV testing data, over the study period we found a decline in HPV types 16 and 18, significant decreases in HPV types 31, 33, and 45 (suggesting cross-protection), and a nonsignificant increase in HPV 51. In addition, among nonvaccinated women, HPV types 16 and 18 infections were significantly lower in 2013 than in 2009. Our results preliminarily indicate herd immunity and sustained effectiveness of the bivalent vaccine on virologic outcomes at the population level.
Publisher: United States: U.S. National Center for Infectious Diseases
Language: English
Identifier: ISSN: 1080-6040
EISSN: 1080-6059
DOI: 10.3201/eid2201.150736
PMID: 26692336
Source: Centers for Disease Control and Prevention
U.S. Government Documents
GFMER Free Medical Journals
MEDLINE
PubMed Central
DOAJ Directory of Open Access Journals

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013

COPYRIGHT 2016 U.S. National Center for Infectious Diseases ;COPYRIGHT 2016 U.S. National Center for Infectious Diseases ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2201.150736 ;PMID: 26692336

Searching Remote Databases, Please Wait